PPOKF yields 2.96% · PFE yields 6.20%● Live data
📍 PPOKF pulled ahead of the other in Year 1
Combined, PPOKF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PPOKF + PFE for your $10,000?
PT Charoen Pokphand Indonesia Tbk produces and sells poultry feed, processed chicken, and day old chicks (DOC) in Indonesia. The company offers broiler and layer poultry feed; and various poultry feed products for parent stock, duck, native chicken, fighting cock, and quail, as well as feed for cattle and swine under the brands of HI-PRO, HI-PRO-VITE, BINTANG, BONAVITE, ROYAL FEED, TURBO FEED, and TIJI. It also provides various types of DOC, such as broiler DOC; layer DOC; and other DOC, such as DOC for parent stock and male layer. In addition, the company sells various food products under the Golden Fiesta, Fiesta, Champ, and Okey brands. Further, it is involved in poultry farming and beverage activities; trading of processed food and medicine; the production of plastic packaging products; the production and distribution of raw material for feed; and the operation of restaurants and convenience stores. The company was formerly known as PT Charoen Pokphand Indonesia Animal Feedmill Co. Limited. PT Charoen Pokphand Indonesia Tbk was founded in 1972 and is headquartered in Jakarta, Indonesia. PT Charoen Pokphand Indonesia Tbk is a subsidiary of PT Charoen Pokphand Indonesia Group.
Full PPOKF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.